Hangzhou TianMuShan Pharmaceutical EnterpriseLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Hangzhou TianMuShan Pharmaceutical EnterpriseLtd has a total shareholder equity of CN¥56.5M and total debt of CN¥90.8M, which brings its debt-to-equity ratio to 160.6%. Its total assets and total liabilities are CN¥366.4M and CN¥309.8M respectively.
Belangrijke informatie
160.6%
Verhouding schuld/eigen vermogen
CN¥90.77m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥30.43m |
| Aandelen | CN¥56.51m |
| Totaal verplichtingen | CN¥309.84m |
| Totaal activa | CN¥366.35m |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 600671's short term assets (CN¥150.3M) do not cover its short term liabilities (CN¥230.3M).
Langlopende schulden: 600671's short term assets (CN¥150.3M) exceed its long term liabilities (CN¥79.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 600671's net debt to equity ratio (106.8%) is considered high.
Schuld verminderen: 600671's debt to equity ratio has increased from 92.1% to 160.6% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 600671 has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: 600671 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.9% each year